A review of H7 subtype avian influenza virus.
- Author:
Wen-Fei ZHU
1
;
Rong-Bao GAO
;
Da-Yan WANG
;
Lei YANG
;
Yun ZHU
;
Yue-Long SHU
Author Information
1. World Health Organization Global Influenza Collaboration Centre for Reference and Research, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, Ministry of Health, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing 102206, China. wenfei@cnic.org.cn
- Publication Type:Journal Article
- MeSH:
Animals;
Chickens;
Ducks;
Humans;
Influenza A virus;
genetics;
isolation & purification;
pathogenicity;
physiology;
Influenza Vaccines;
genetics;
immunology;
Influenza in Birds;
immunology;
prevention & control;
virology;
Influenza, Human;
immunology;
prevention & control;
virology;
Poultry Diseases;
immunology;
prevention & control;
virology;
Turkeys
- From:
Chinese Journal of Virology
2013;29(3):245-249
- CountryChina
- Language:Chinese
-
Abstract:
Since 2002, H7 subtype avian influenza viruses (AIVs) have caused more than 100 human infection cases in the Netherlands, Italy, Canada, the United States, and the United Kingdom, with clinical illness ranging from conjunctivitis to mild upper respiratory illness to pneumonia. On March 31st, three fatal cases caused by infection of a novel reassortant H7N9 subtype were reported in Shanghai City and Anhui Province in China. With the ability of H7 subtype to cause severe human disease and the increasing isolation of subtype H7 AIVs, we highlighted the need for continuous surveillance in both humans and animals and characterization of these viruses for the development of vaccines and anti-viral drugs.
